OrganiGram Holdings (FRA:0OG0) Capex-to-Revenue : 0.03 (As of Jun. 2024)

OrganiGram Holdings Capex-to-Revenue Chart

OrganiGram Holdings Annual Data
	Trend	Apr12	Apr13	Apr14	Aug15	Aug16	Aug17	Aug18	Aug19	Aug20	Aug21
Capex-to-Revenue		Get a 7-Day Free Trial					5.79	4.54	1.37	0.91	0.16

OrganiGram Holdings Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Dec23	Mar24	Jun24
Capex-to-Revenue	Get a 7-Day Free Trial															0.14	0.28	0.04	0.02	0.03

Competitive Comparison of OrganiGram Holdings's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, OrganiGram Holdings's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OrganiGram Holdings's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, OrganiGram Holdings's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where OrganiGram Holdings's Capex-to-Revenue falls into.

OrganiGram Holdings Capex-to-Revenue Calculation

OrganiGram Holdings's Capex-to-Revenue for the fiscal year that ended in Aug. 2021 is calculated as

OrganiGram Holdings's Capex-to-Revenue for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OrganiGram Holdings  (FRA:0OG0) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

OrganiGram Holdings Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of OrganiGram Holdings's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

OrganiGram Holdings Business Description